Last updated: 4 months ago
Genenta Science S.P.A. Reports Key Development: Second Amendment with AGC Biologics
Genenta Science S.P.A. files Form 6-K detailing a pivotal agreement with AGC Biologics for exclusive manufacturing. This development enhances their clinical programs in Italy.